Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

CRIS, NHPR, PATK, PWRM, APPY - Stock Review From!



Curis Inc. (Nasdaq:CRIS) announced that the Company will be presenting at the Cowen and Company Healthcare Conference at 2:30 p.m. EST on March 7, 2011, in Boston, Massachusetts. Dan Passeri, Curis’ President and Chief Executive Officer, will provide an overview of the status of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor that is being developed by Curis’ collaborator Genentech. Mr. Passeri will also discuss CUDC-101, CUDC-907, Debio 0932 and Curis' other targeted cancer programs, in addition to other corporate activities.

More At: